Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study

Clinical trial NCT02644044 · UNKNOWN

Trial details

NCT number: NCT02644044
Sponsor: Tel-Aviv Sourasky Medical Center
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

To Evaluate the Effect of Therapy With IT MTX on the Disease Course of Patients With Progressive MS

Start date: 2016-01-01
Primary completion: 2017-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.